A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT00786201 · COMPLETED

Trial details

NCT number: NCT00786201
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Fibrosis

Start date: 2008-12-01
Primary completion: 2012-01-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.